General MedicationsINJECTIONStandard
MARCAINE HYDROCHLORIDE
BUPIVACAINE HYDROCHLORIDE
Standard Dose
0.5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MARCAINE HYDROCHLORIDE is listed in Drugs@FDA under application 016964 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BUPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.5% Sponsor HOSPIRA Submission history Latest submission status date: 2020-08-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview MARCAINE HYDROCHLORIDE is listed in Drugs@FDA under application 016964 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BUPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.5% Sponsor HOSPIRA Submission history Latest submission status date: 2020-08-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.